205 related articles for article (PubMed ID: 31705019)
1. Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling.
Kalpana G; Figy C; Yeung M; Yeung KC
Sci Rep; 2019 Nov; 9(1):16351. PubMed ID: 31705019
[TBL] [Abstract][Full Text] [Related]
2. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA.
Liu Q; Huang X; Li Q; He L; Li S; Chen X; Ouyang Y; Wang X; Lin C
FASEB J; 2020 Aug; 34(8):9959-9971. PubMed ID: 32427399
[TBL] [Abstract][Full Text] [Related]
3. AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion.
Ma Y; Xia Z; Ye C; Lu C; Zhou S; Pan J; Liu C; Zhang J; Liu T; Hu T; Xie L; Wu G; Zhao Y
Aging (Albany NY); 2019 Jun; 11(12):3969-3992. PubMed ID: 31219799
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.
Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D
Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072
[TBL] [Abstract][Full Text] [Related]
5. The RhoA dependent anti-metastatic function of RKIP in breast cancer.
Kalpana G; Figy C; Feng J; Tipton C; De Castro JN; Bach VN; Borile C; LaSalla A; Odeh HN; Yeung M; Garcia-Mata R; Yeung KC
Sci Rep; 2021 Aug; 11(1):17455. PubMed ID: 34465801
[TBL] [Abstract][Full Text] [Related]
6. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
[TBL] [Abstract][Full Text] [Related]
7. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
8. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.
Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W
Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer.
Guo J; Yu X; Gu J; Lin Z; Zhao G; Xu F; Lu C; Ge D
Tumour Biol; 2016 May; 37(5):6371-8. PubMed ID: 26631033
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway.
Yuan W; Guo YQ; Li XY; Deng MZ; Shen ZH; Bo CB; Dai YF; Huang MY; Yang ZY; Quan YS; Tian L; Wang X
Oncotarget; 2016 Sep; 7(37):60230-60244. PubMed ID: 27517626
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.
Lefort S; Thuleau A; Kieffer Y; Sirven P; Bieche I; Marangoni E; Vincent-Salomon A; Mechta-Grigoriou F
Oncogene; 2017 Mar; 36(9):1211-1222. PubMed ID: 27669438
[TBL] [Abstract][Full Text] [Related]
12. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p.
Yu X; Wang D; Wang X; Sun S; Zhang Y; Wang S; Miao R; Xu X; Qu X
J Exp Clin Cancer Res; 2019 Jan; 38(1):32. PubMed ID: 30678736
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
15. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
16. PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.
Struckhoff AP; Rana MK; Kher SS; Burow ME; Hagan JL; Del Valle L; Worthylake RA
J Cell Sci; 2013 Oct; 126(Pt 19):4514-26. PubMed ID: 23868972
[TBL] [Abstract][Full Text] [Related]
17. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.
Yang Y; Leonard M; Zhang Y; Zhao D; Mahmoud C; Khan S; Wang J; Lower EE; Zhang X
Cancer Res; 2018 Jan; 78(2):422-435. PubMed ID: 29187405
[TBL] [Abstract][Full Text] [Related]
18. Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
Li D; Wang H; Ding Y; Zhang Z; Zheng Z; Dong J; Kim H; Meng X; Zhou Q; Zhou J; Fang L; Shen Q
Cancer Lett; 2018 Jun; 424():97-108. PubMed ID: 29580806
[TBL] [Abstract][Full Text] [Related]
19. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
[TBL] [Abstract][Full Text] [Related]
20. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
Wang L; Shi H; Liu Y; Zhang W; Duan X; Li M; Shi X; Wang T
Int J Oncol; 2019 Aug; 55(2):473-487. PubMed ID: 31173185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]